克罗恩病术后复发当前与新版内镜评分观察者间一致性研究
荷兰16名炎症性肠病专家对66例术后克罗恩病患者的71段内镜视频,用改良Rutgeerts评分(mRS)、REMIND评分和更新版Rutgeerts评分评估炎症程度,Fleiss加权kappa分别为0.67、新吻合口病变0.46/新末端回肠0.73、0.69,更新版与mRS一致性均属高,REMIND吻合口病变仅中等。
要点
- 改良Rutgeerts评分观察者间一致性为高,加权kappa 0.67(95%CI 0.59-0.74)。
- 更新版Rutgeerts评分一致性为高,加权kappa 0.69(95%CI 0.62-0.77)。
- REMIND评分新末端回肠病变一致性为高(kappa 0.73),吻合口病变仅中等(kappa 0.46)。
核心结论
- 改良Rutgeerts评分与更新版Rutgeerts评分的观察者间一致性均为高。
- REMIND评分中,新末端回肠病变的观察者间一致性为高,而吻合口病变仅为中等。
- 由于临床治疗决策和临床研究结局均基于这些评估,进一步改善观察者间一致性至关重要。
研究设计与样本
- 荷兰16名学术与非学术炎症性肠病专家参与评估。
- 评估对象为来自9家荷兰中心的66例术后克罗恩病患者的内镜视频共71段。
- 每段视频由4名胃肠病学家分别用改良Rutgeerts评分、REMIND评分和更新版Rutgeerts评分评估炎症程度。
- 采用Fleiss加权kappa评估观察者间一致性。
主要发现
- 改良Rutgeerts评分的Fleiss加权kappa为0.67(95%CI 0.59-0.74)。
- REMIND评分中新末端回肠病变的加权kappa为0.73(95%CI 0.65-0.80),吻合口病变为0.46(95%CI 0.35-0.58)。
- 更新版Rutgeerts评分的加权kappa为0.69(95%CI 0.62-0.77)。
- 回肠体部、回肠入口、新末端回肠、结肠及回肠盲袢病变的加权kappa分别为0.61(95%CI 0.49-0.73)、0.63(95%CI 0.54-0.72)、0.61(95%CI 0.49-0.74)、0.83(95%CI 0.62-1.00)和0.68(95%CI 0.46-0.89)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The modified Rutgeerts score (mRS) is widely used for the assessment of endoscopic postoperative recurrence (ePOR) in Crohn's disease (CD) after ileocolic resection to guide therapeutic decisions. To improve the validity and prognostic value of this endoscopic assessment, 2 new scores have been proposed. This study assessed the interobserver agreement of the current score (mRS) and the new endoscopic score for ePOR in CD. METHODS: Sixteen Dutch academic and nonacademic inflammatory bowel disease specialists assessed endoscopic videos (n = 71) of postoperative CD patients (n = 66) retrieved from 9 Dutch centers. Each video was assessed for degree of inflammation by 4 gastroenterologists using the mRS and the new proposed endoscopic score: the REMIND score (separate score of anastomosis and neoterminal ileum) and the updated Rutgeerts score (assessment of lesions at the anastomotic line, ileal inlet, ileal body, and neoterminal ileum). In addition, lesions at the ileal body, ileal inlet, neoterminal ileum, and colonic and/or ileal blind loop were separately assessed. Interobserver agreement was assessed by using Fleiss' weighted kappa. RESULTS: Fleiss' weighted kappa for the mRS was .67 (95% confidence interval [CI], .59-.74). The weighted kappa for the REMIND score was .73 (95% CI, .65-.80) for lesions in the neoterminal ileum and .46 (95% CI, .35-.58) for anastomotic lesions. The weighted kappa for the updated Rutgeerts score was .69 (95% CI, .62-.77). The weighted kappa for lesions in the ileal body, ileal inlet, neoterminal ileum, and colonic and ileal blind loop was .61 (95% CI, .49-.73), .63 (95% CI, .54-.72), .61 (95% CI, .49-.74), .83 (95% CI, .62-1.00) and .68 (95% CI, .46-.89), respectively. CONCLUSIONS: The interobserver agreement of the mRS is substantial. Similarly, the interobserver agreement is substantial for the updated Rutgeerts score. According to the REMIND score, the interobserver agreement was substantial for lesions in the neoterminal ileum, although only moderate for anastomotic lesions. Because therapeutic decisions in clinical practice are based on these assessments, and these scores are used as outcome measure in clinical studies, further improvement of the interobserver agreement is essential.
引用
- Bak MTJ, Hammoudi N, Allez M, et al. Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn's disease. Gastrointest Endosc. 2024. PMID: 38462057. doi:10.1016/j.gie.2024.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。